These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7823067)

  • 1. Which factors predict cognitive decline in Parkinson's disease?
    Caparros-Lefebvre D; Pécheux N; Petit V; Duhamel A; Petit H
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):51-5. PubMed ID: 7823067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive function assessment in idiopathic Parkinson's disease.
    Piovezan MR; Teive HA; Piovesan EJ; Mader MJ; Werneck LC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):942-6. PubMed ID: 18094850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up].
    Giménez-Roldán S; Mateo D; Dobato JL
    Neurologia; 1997 Mar; 12(3):130-5. PubMed ID: 9198454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive slowing in Parkinson's disease resolves after practice.
    Press DZ; Mechanic DJ; Tarsy D; Manoach DS
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):524-8. PubMed ID: 12397144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study.
    Arie L; Herman T; Shema-Shiratzky S; Giladi N; Hausdorff JM
    J Neurol; 2017 Oct; 264(10):2149-2157. PubMed ID: 28879438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of dopamine agonist pramipexole (mirapex) on tremor, cognitive and affective impairment in patients with Parkinson's disease].
    Levin OS; Nesterova OS; Otcheskaia OV; Zhuravleva EIu; Artemova IIu; Khozova AA; Ismailov AM; Lisenker LN; Vdovichenko TV; Rotor LD; Ganzula PA; Ivanov AK; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(8):36-41. PubMed ID: 19738567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
    Pillon B; Dubois B; Cusimano G; Bonnet AM; Lhermitte F; Agid Y
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):201-6. PubMed ID: 2703838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.
    Schüpbach WM; Chastan N; Welter ML; Houeto JL; Mesnage V; Bonnet AM; Czernecki V; Maltête D; Hartmann A; Mallet L; Pidoux B; Dormont D; Navarro S; Cornu P; Mallet A; Agid Y
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1640-4. PubMed ID: 16291886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.
    Liu C; Cholerton B; Shi M; Ginghina C; Cain KC; Auinger P; ; Zhang J
    Parkinsonism Relat Disord; 2015 Mar; 21(3):271-6. PubMed ID: 25596881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.